PGP and cancer: These compounds enhanced the cytotoxic activity of several well-known anticancer drugs including colchicine, vinblastine and paclitaxel, which are substrates for P-gp, significantly increasing the sensitivity of cancer cells with a P-gp overexpressed phenotype (KB-C2) in a dose-dependent manner.